BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34286351)

  • 21. Comparative evaluation of lesion enhancement using 1 M gadobutrol vs. 2 conventional gadolinium chelates, all at a dose of 0.1 mmol/kg, in a rat brain tumor model at 3 T.
    Attenberger UI; Runge VM; Jackson CB; Baumann S; Birkemeier K; Michaely HJ; Schoenberg SO; Reiser MF; Wintersperger BJ
    Invest Radiol; 2009 May; 44(5):251-6. PubMed ID: 19550376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progressive T1 Shortening of the Dentate Nucleus in Patients With Multiple Sclerosis: Result of Multiple Administrations of Linear Gadolinium Contrast Agents Versus Intrinsic Disease.
    Malhotra A; LeSar B; Wu X; Durand D; Das N; Anzai Y; Sanelli P
    AJR Am J Roentgenol; 2018 Nov; 211(5):1099-1105. PubMed ID: 30160975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The switch from Gd-DTPA to Gd-DOTA is not associated with decrease of the T1 signal intensity of the pallidus and dentate in a pediatric population.
    Gulino P; Bianchi A; Diciotti S; Scionti A; Sali L; Papadopulos P; Mascalchi M
    Acta Radiol; 2021 Mar; 62(3):368-376. PubMed ID: 32529894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent.
    Radbruch A; Weberling LD; Kieslich PJ; Eidel O; Burth S; Kickingereder P; Heiland S; Wick W; Schlemmer HP; Bendszus M
    Radiology; 2015 Jun; 275(3):783-91. PubMed ID: 25848905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Signal intensity at unenhanced T1-weighted magnetic resonance in the globus pallidus and dentate nucleus after serial administrations of a macrocyclic gadolinium-based contrast agent in children.
    Rossi Espagnet MC; Bernardi B; Pasquini L; Figà-Talamanca L; Tomà P; Napolitano A
    Pediatr Radiol; 2017 Sep; 47(10):1345-1352. PubMed ID: 28526896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T1 signal intensity in the dentate nucleus after the administration of the macrocyclic gadolinium-based contrast agent gadoterate meglumine: An observational study.
    Ramalho J; Semelka RC; Cruz J; Morais T; Ramalho M
    Radiologia (Engl Ed); 2022; 64(5):397-406. PubMed ID: 36243439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gadolinium Brain Deposition after Macrocyclic Gadolinium Administration: A Pediatric Case-Control Study.
    Tibussek D; Rademacher C; Caspers J; Turowski B; Schaper J; Antoch G; Klee D
    Radiology; 2017 Oct; 285(1):223-230. PubMed ID: 28640695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dentate Nucleus Signal Intensity Decrease on T1-weighted MR Images after Switching from Gadopentetate Dimeglumine to Gadobutrol.
    Behzadi AH; Farooq Z; Zhao Y; Shih G; Prince MR
    Radiology; 2018 Jun; 287(3):816-823. PubMed ID: 29533723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pediatric Brain: No Increased Signal Intensity in the Dentate Nucleus on Unenhanced T1-weighted MR Images after Consecutive Exposure to a Macrocyclic Gadolinium-based Contrast Agent.
    Radbruch A; Haase R; Kickingereder P; Bäumer P; Bickelhaupt S; Paech D; Wick W; Schlemmer HP; Seitz A; Bendszus M
    Radiology; 2017 Jun; 283(3):828-836. PubMed ID: 28273007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gadolinium deposition in the brain is related to various contrast agents: a matched case-control study.
    Bi Q; Li H; Du J; Li H; Li Q; Wang J; Huang Y; Gong X
    Clin Radiol; 2022 Apr; 77(4):299-306. PubMed ID: 35094817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Linear gadolinium-based contrast agent (gadodiamide and gadopentetate dimeglumine)-induced high signal intensity on unenhanced T
    Ichikawa S; Omiya Y; Onishi H; Motosugi U
    J Magn Reson Imaging; 2019 Apr; 49(4):1046-1052. PubMed ID: 30307671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term Excretion of Gadolinium-based Contrast Agents: Linear versus Macrocyclic Agents in an Experimental Rat Model.
    Jost G; Frenzel T; Boyken J; Lohrke J; Nischwitz V; Pietsch H
    Radiology; 2019 Feb; 290(2):340-348. PubMed ID: 30422091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Signal changes in enhanced T1-weighted images related to gadolinium retention: A three-time-point imaging study.
    Lersy F; Diepenbroek AL; Lamy J; Willaume T; Bierry G; Cotton F; Kremer S
    J Neuroradiol; 2021 Mar; 48(2):82-87. PubMed ID: 32615207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Signal Increase on Unenhanced T1-Weighted Images in the Rat Brain After Repeated, Extended Doses of Gadolinium-Based Contrast Agents: Comparison of Linear and Macrocyclic Agents.
    Jost G; Lenhard DC; Sieber MA; Lohrke J; Frenzel T; Pietsch H
    Invest Radiol; 2016 Feb; 51(2):83-9. PubMed ID: 26606548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of at Least 10 Serial Gadobutrol Administrations on Brain Signal Intensity Ratios on T1-Weighted MRI in Children: A Matched Case-Control Study.
    Ozturk K; Nascene D
    AJR Am J Roentgenol; 2021 Sep; 217(3):753-760. PubMed ID: 33112200
    [No Abstract]   [Full Text] [Related]  

  • 36. Signal intensity change on unenhanced T1-weighted images in dentate nucleus following gadobenate dimeglumine in patients with and without previous multiple administrations of gadodiamide.
    Ramalho J; Semelka RC; AlObaidy M; Ramalho M; Nunes RH; Castillo M
    Eur Radiol; 2016 Nov; 26(11):4080-4088. PubMed ID: 26911888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of increased signal intensity in the dentate nucleus after repeated administration of a macrocyclic contrast agent in multiple sclerosis: An observational study.
    Eisele P; Alonso A; Szabo K; Ebert A; Ong M; Schoenberg SO; Gass A
    Medicine (Baltimore); 2016 Sep; 95(39):e4624. PubMed ID: 27684794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dentate Nucleus Signal Intensity Increases Following Repeated Gadobenate Dimeglumine Administrations: A Retrospective Analysis.
    Nguyen NC; Molnar TT; Cummin LG; Kanal E
    Radiology; 2020 Jul; 296(1):122-130. PubMed ID: 32343210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffusion-weighted imaging of the dentate nucleus after repeated application of gadolinium-based contrast agents in multiple sclerosis.
    Eisele P; Szabo K; Ebert A; Radbruch A; Platten M; Schoenberg SO; Gass A
    Magn Reson Imaging; 2019 May; 58():1-5. PubMed ID: 30630068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Signal Changes in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-Weighted Magnetic Resonance Images After Intrathecal Administration of Macrocyclic Gadolinium Contrast Agent.
    Ozturk K; Nas OF; Soylu E; Hakyemez B
    Invest Radiol; 2018 Sep; 53(9):535-540. PubMed ID: 29727401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.